Skip to content

Effect Evaluation and Mechanism Study of Chaihu Guizhi Ganjiang Decoction on Chronic Gastritis with Gallbladder-heat and Spleen-cold Syndrome

Effect Evaluation and Mechanism Study of Chaihu Guizhi Ganjiang Decoction on Chronic Gastritis with Gallbladder-heat and Spleen-cold Syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200006835
Enrollment
Unknown
Registered
2022-11-28
Start date
2022-12-31
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Non-atrophic Gastritis with Gallbladder-heat and Spleen-cold Syndrome

Interventions

Treatment group:Chaihu Guizhi Ganjiang Decoction granules

Sponsors

Shanghai Changzheng Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for chronic non-atrophic gastritis 2. Meet the syndrome diagnosis of gallbladder heat and spleen cold 3. Older than 18 and younger than 75 4. Sign the informed consent

Exclusion criteria

Exclusion criteria: 1. Helicobacter pylori infection in chronic non-atrophic gastritis 2. Other chronic diseases or serious diseases (such as heart disease, renal failure, etc.) 3. Other diseases that affect consciousness and can not complete normal doctor-patient communication 4. Long-term use of similar drugs that may affect this study

Design outcomes

Primary

MeasureTime frame
Curative effect of TCM syndrome;

Secondary

MeasureTime frame
Efficacy evaluation of major symptoms of chronic non-atrophic gastritis;

Countries

China

Contacts

Public ContactYue Xiaoqiang
yuexiaoqiang@163.com13917962316

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026